Trademark: 79131973
Status Date
Tuesday, October 4, 2022
Registration Number
4557910
Registration Date
Tuesday, July 1, 2014
Filing Date
Wednesday, October 3, 2012
Published for Opposition
Tuesday, April 15, 2014
Cancellation Date
Tuesday, October 4, 2022
5 Pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilization treatment or for treatment of varicose veins, or arterio-venous malformations; sterilizing preparations
1 Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the manufacture of injectable foams
44 Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical evaluation of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical services provided to post-treatment and homecare patients in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; providing outpatient medical services regarding the administering of medications and therapy in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment
10 Needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions
42 Scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology
VEN VERSA
Color is not claimed as a feature of the mark.
Apr 23, 2023
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Apr 23, 2023
Death Of International Registration
Mar 13, 2022
Total Invalidation Processed By The Ib
Feb 19, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Feb 19, 2022
Invalidation Processed
Jan 8, 2022
New Representative At Ib Received
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
Oct 13, 2017
New Representative At Ib Received
Oct 17, 2014
Final Decision Transaction Processed By Ib
Oct 2, 2014
Final Disposition Notice Sent To Ib
Oct 2, 2014
Final Disposition Processed
Oct 1, 2014
Final Disposition Notice Created, To Be Sent To Ib
Jul 1, 2014
Registered-Principal Register
Apr 15, 2014
Published For Opposition
Apr 10, 2014
Notification Processed By Ib
Mar 26, 2014
Notification Of Possible Opposition Sent To Ib
Mar 26, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 26, 2014
Notice Of Publication
Mar 7, 2014
Law Office Publication Review Completed
Mar 6, 2014
Assigned To Lie
Feb 15, 2014
Approved For Pub - Principal Register
Jan 23, 2014
Teas/Email Correspondence Entered
Jan 23, 2014
Correspondence Received In Law Office
Jan 23, 2014
Teas Response To Office Action Received
Aug 11, 2013
Refusal Processed By Ib
Jul 23, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Jul 18, 2013
Refusal Processed By Mpu
Jul 18, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Jul 17, 2013
Non-Final Action Written
Jul 13, 2013
Application Filing Receipt Mailed
Jul 9, 2013
Assigned To Examiner
Jul 9, 2013
New Application Office Supplied Data Entered
Jul 5, 2013
Limitation From Original Application Entered
Jul 4, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
